Livzon Pharmaceutical Dividend yield

Livzon Pharmaceutical is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Livzon Pharmaceutical is a company from China, and his stocks are publicly traded.

Livzon Pharmaceutical stock dividend

Livzon Pharmaceutical paid a total dividend of 533 million HKD last year, for a market value of 7,704 millions (Market Cap 3,767 millions). Livzon Pharmaceutical dividend per share is 1.72 HKD, and his stock market price 24.85 HKD.

According to the chart below, where dividend yield is displayed, Livzon Pharmaceutical has a dividend yield of 6.93%, which is higher than the amount offered by both the market average and companies from China. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Livzon Pharmaceutical stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best China dividend stocks list.

Livzon Pharmaceutical Dividend Payout

About the ability of Livzon Pharmaceutical to maintain his current dividend of HKD 1.72 per share, an amount that accounts for 6.93%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Livzon Pharmaceutical payout on ernings is currently 70.49%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Livzon Pharmaceutical can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Livzon Pharmaceutical is HKD 3.31 per share, which is higher than the dividend per share paid by the company of HKD 1.72, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Livzon Pharmaceutical, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Livzon Pharmaceutical Group Dividend History

Below you will find a table with the historical evolution of Livzon Pharmaceutical Group's dividend stock, both in percentage and in HKD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	HKD	Paypout	Shares*
Present	6.93%	1.72	70.49%	310
2022	5.56%	1.46	65.77%	310
2021	5.28%	1.50	64.66%	313
2020	4.54%	1.36	80.47%	320
2019	4.33%	1.05	78.95%	320
2018	8.31%	1.89	26.58%	246
2017	0.71%	0.44	25.00%	189

*In millions

Livzon Pharmaceutical Stock performance

Finally, last moth Livzon Pharmaceutical showed a return of -6.60% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 11.90% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.